FIELD: medicine.
SUBSTANCE: patient's blood serum one-dimensional electrophoresis is performed, and an electrophoretic distribution spectrum of serum protein is evaluated. If the proteins with molecular weight 128, 114, 21 kDa are found, paranoid schizophrenia is diagnosed; the proteins with molecular weight 88 and 32 kDa enable diagnosing simple schizophrenia, while acute polymorphic psychosis is shown by the proteins with molecular weight 65 and 38 kDa.
EFFECT: using the given technique enables performing the differential diagnosis of simple, paranoid schizophrenia and acute polymorphic psychosis, and prescribing an individual therapy of a patient adequate to the diagnosis.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LABORATORY METHOD OF DIAGNOSING BIPOLAR AFFECTIVE DISORDER | 2013 |
|
RU2558056C2 |
| LABORATORY DIAGNOSTIC TECHNIQUE FOR SCHIZOTYPAL DISORDER | 2014 |
|
RU2569741C1 |
| METHOD FOR PREDICTION OF THE PROBABILITY OF AN UNFAVORABLE OUTCOME IN RELATION TO THE SOCIAL POSTPSYCHOTIC FUNCTIONING OF THE PATIENTS WITH ENDOGENOUS PSYCHIC DISEASES | 2018 |
|
RU2706216C1 |
| PROTEINS DCLK1 AND RIPK1 BIOMARKERS OF SIMPLE SCHIZOPHRENIA | 2021 |
|
RU2788149C1 |
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
| METHOD OF ESTIMATION OF PATIENT'S MENTAL CONDITION WITH ENDOGENIC MENTAL DISORDERS AT THEIR CLINICAL EXAMINATION AND METHOD OF COMPLEX EVALUATION OF THE STATE OF THE IMMUNE SYSTEM OF SUCH PATIENTS | 2016 |
|
RU2648745C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
| METHOD OF TREATING SCHIZOPHRENIA | 2011 |
|
RU2484836C2 |
| METHOD FOR PREDICTING INFRINGEMENTS IN COMPLIANCE WITH THERAPY FOR FURTHER CORRECTION OF PATIENTS WITH SCIZOPHRENIA | 2016 |
|
RU2611934C1 |
| LABORATORY METHOD FOR DIAGNOSIS OF LEADING NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA | 2015 |
|
RU2578957C1 |
